LianBio American Depositary Shares
LIAN
LIAN was delisted on the 18th of March, 2024.
44 hedge funds and large institutions have $168M invested in LianBio American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 6 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 6
0% more funds holding
Funds holding: 44 → 44 (0)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
10% less capital invested
Capital invested by funds: $187M → $168M (-$19.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$2.39M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.66M |
| 3 |
Barclays
London,
United Kingdom
|
+$642K |
| 4 |
Citigroup
New York
|
+$619K |
| 5 |
Renaissance Technologies
New York
|
+$608K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$9.98M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$1.08M |
| 3 |
ACM
Altium Capital Management
New York
|
-$681K |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$207K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$70K |
LIAN Hedge Fund Activity: Q3 2022 in Review
44 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in LianBio American Depositary Shares (LIAN) for Q3 2022, worth a combined $168M — down 10% from $187M a quarter earlier.
Fund positioning in LIAN was balanced in Q3 2022: 6 funds opened new positions, 6 closed out, 18 added to existing stakes and 6 trimmed.
The largest buyer was Perceptive Advisors, adding an estimated $2.39M. The largest seller was RA Capital Management, exiting entirely with an estimated $9.98M sold.
- 44 institutional investors held LianBio American Depositary Shares (LIAN) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $168M of LianBio American Depositary Shares stock for Q3 2022, down 10% quarter-over-quarter.
- 6 funds opened new LianBio American Depositary Shares positions in Q3 2022 and 6 closed out, a net change of 0 holders.
- The largest LianBio American Depositary Shares buyer in Q3 2022 was Perceptive Advisors, an estimated $2.39M added.
- The largest LianBio American Depositary Shares seller in Q3 2022 was RA Capital Management, an estimated $9.98M sold.
Based on aggregated 13F filings for Q3 2022.